Design and Synthesis of Diazatricyclodecane Agonists of the G-Protein-Coupled Receptor 119

被引:27
|
作者
Darout, Etzer [5 ,6 ,7 ,8 ]
Robinson, Ralph P. [1 ,2 ,3 ,4 ]
McClure, Kim F. [5 ,6 ,7 ,8 ]
Corbett, Matthew [1 ,2 ,3 ,4 ]
Li, Bryan [1 ,2 ,3 ,4 ]
Shavnya, Andrei [1 ,2 ,3 ,4 ]
Andrews, Melissa P. [1 ,2 ,3 ,4 ]
Jones, Christopher S. [1 ,2 ,3 ,4 ]
Li, Qifang [1 ,2 ,3 ,4 ]
Minich, Martha L. [1 ,2 ,3 ,4 ]
Mascitti, Vincent [1 ,2 ,3 ,4 ]
Guimaraes, Cristiano R. W. [5 ,6 ,7 ,8 ]
Munchhof, Michael J. [1 ,2 ,3 ,4 ]
Bahnck, Kevin B. [1 ,2 ,3 ,4 ]
Cai, Cuiman [1 ,2 ,3 ,4 ]
Price, David A. [5 ,6 ,7 ,8 ]
Liras, Spiros [5 ,6 ,7 ,8 ]
Bonin, Paul D. [1 ,2 ,3 ,4 ]
Cornelius, Peter [1 ,2 ,3 ,4 ]
Wang, Ruduan [1 ,2 ,3 ,4 ]
Bagdasarian, Victoria [1 ,2 ,3 ,4 ]
Sobota, Colleen P. [1 ,2 ,3 ,4 ]
Hornby, Sam [1 ,2 ,3 ,4 ]
Masterson, Victoria M. [1 ,2 ,3 ,4 ]
Joseph, Reena M. [1 ,2 ,3 ,4 ]
Kalgutkar, Amit S. [5 ,6 ,7 ,8 ]
Chen, Yue [1 ,2 ,3 ,4 ]
机构
[1] Pfizer Worldwide Res & Dev, Dept Med Chem, Groton, CT 06340 USA
[2] Pfizer Worldwide Res & Dev, Dept Discovery Biol, Groton, CT 06340 USA
[3] Pfizer Worldwide Res & Dev, Dept Drug Metab, Groton, CT 06340 USA
[4] Pfizer Worldwide Res & Dev, Dept Pharmaceut Sci, Groton, CT 06340 USA
[5] Pfizer Worldwide Res & Dev, Dept Med Chem, Cambridge, MA 02139 USA
[6] Pfizer Worldwide Res & Dev, Dept Discovery Biol, Cambridge, MA 02139 USA
[7] Pfizer Worldwide Res & Dev, Dept Drug Metab, Cambridge, MA 02139 USA
[8] Pfizer Worldwide Res & Dev, Dept Pharmaceut Sci, Cambridge, MA 02139 USA
关键词
4-AMINO-2-PHENYLPYRIMIDINE DERIVATIVES; GPR119; AGONISTS; DISCOVERY; SERIES; EFFICIENCY; POTENT; OPTIMIZATION; SAFETY; ACID; LEAD;
D O I
10.1021/jm301626p
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of GPR119 agonists based on a 2,6-diazatricyclo[3.3.1.1 similar to 3,7,similar to]decane ring system is described. Also provided is a detailed account of the development of a multigram scale synthesis of the diazatricyclic ring system, which was achieved using a Hofmann-Loffler-Freytag reaction as the key step. The basis for the use of this complex framework lies in an attempt to constrain one end of the molecule in the "agonist conformation" as was previously described for 3-oxa-7-aza-bicyclo[3.3.1]nonanes. Optimization of carbamate analogues of the diazatricylic compounds led to the identification of 32i as a potent agonist of the GPR119 receptor with low unbound human liver microsomal clearance. The use of an agonist response weighted ligand lipophilic efficiency (LLE) termed AgLLE is discussed along with the issues of applying efficiency measures to agonist programs. Ultimately, solubility limited absorption and poor exposure reduced further interest in these molecules.
引用
收藏
页码:301 / 319
页数:19
相关论文
共 50 条
  • [41] Development of Novel G-Protein-Coupled Receptor 54 Agonists with Resistance to Degradation by Matrix Metalloproteinase
    Tomita, Kenji
    Oishi, Shinya
    Ohno, Hiroaki
    Peiper, Stephen C.
    Fujii, Nobutaka
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7645 - 7649
  • [42] Identification of Surrogate Agonists and Antagonists for Orphan G-Protein-Coupled Receptor GPR139
    Hu, Liaoyuan A.
    Tang, Pauline M.
    Eslahi, Nima K.
    Zhou, Tian
    Barbosa, Joseph
    Liu, Qingyun
    JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (07) : 789 - 797
  • [43] Activation of the G-Protein-Coupled Receptor 119: A Conformation-Based Hypothesis for Understanding Agonist Response
    McClure, Kim F.
    Darout, Etzer
    Guimaraes, Cristiano R. W.
    DeNinno, Michael P.
    Mascitti, Vincent
    Munchhof, Michael J.
    Robinson, Ralph P.
    Kohrt, Jeffrey
    Harris, Anthony R.
    Moore, Dianna E.
    Li, Bryan
    Samp, Lacey
    Lefker, Bruce A.
    Futatsugi, Kentaro
    Kung, Daniel
    Bonin, Paul D.
    Cornelius, Peter
    Wang, Ruduan
    Salter, Eben
    Hornby, Sam
    Kalgutkar, Amit S.
    Chen, Yue
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1948 - 1952
  • [44] Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design
    Vaidehi, Nagarajan
    DRUG DISCOVERY TODAY, 2010, 15 (21-22) : 951 - 957
  • [45] G-protein-coupled receptor kinases in cardiovascular conditions: focus on G-protein-coupled receptor kinase 2, a gain in translational medicine
    Campanile, Alfonso
    Iaccarino, Guido
    BIOMARKERS IN MEDICINE, 2009, 3 (05) : 525 - 540
  • [46] G-protein-coupled receptor kinases: Mediators of receptor desensitization
    Loudon, RP
    DRUG NEWS & PERSPECTIVES, 1996, 9 (10) : 592 - 600
  • [47] G-protein-coupled receptor heterodimerization modulates receptor function
    Bryen A. Jordan
    Lakshmi A. Devi
    Nature, 1999, 399 : 697 - 700
  • [48] Reply: receptor specificity of G-protein-coupled receptor kinases
    Gainetdinov, RR
    Premont, RT
    Caron, MG
    Lefkowitz, RJ
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) : 366 - 367
  • [49] G-protein-coupled receptor heterodimerization modulates receptor function
    Jordan, BA
    Devi, LA
    NATURE, 1999, 399 (6737) : 697 - 700
  • [50] G-protein-coupled receptor dimerization: modulation of receptor function
    Rios, CD
    Jordan, BA
    Gomes, I
    Devi, LA
    PHARMACOLOGY & THERAPEUTICS, 2001, 92 (2-3) : 71 - 87